Pages that link to "Q24633887"
Jump to navigation
Jump to search
The following pages link to An overview of sarcopenia: facts and numbers on prevalence and clinical impact (Q24633887):
Displaying 50 items.
- The anabolic catabolic transforming agent (ACTA) espindolol increases muscle mass and decreases fat mass in old rats (Q24564273) (← links)
- Nutritional supplementation in patients with chronic obstructive pulmonary disease (Q26773029) (← links)
- Redox Characterization of Functioning Skeletal Muscle (Q26774782) (← links)
- Vitamin D signaling in myogenesis: potential for treatment of sarcopenia (Q26849642) (← links)
- Oxidative system in aged skeletal muscle (Q28383588) (← links)
- Relationship between human aging muscle and oxidative system pathway (Q28385037) (← links)
- Vitamin E in sarcopenia: current evidences on its role in prevention and treatment (Q28390862) (← links)
- Rationale for antioxidant supplementation in sarcopenia (Q28395964) (← links)
- Myopenia-a new universal term for muscle wasting (Q28741675) (← links)
- Prevalence of sarcopenia in older Brazilians: A systematic review and meta-analysis. (Q30251945) (← links)
- Age-associated differences in triceps surae muscle composition and strength - an MRI-based cross-sectional comparison of contractile, adipose and connective tissue. (Q30831831) (← links)
- Identifying Sarcopenia in Metabolic Syndrome: Data from the Berlin Aging Study II. (Q30986817) (← links)
- Are we closer to having drugs to treat muscle wasting disease? (Q33741103) (← links)
- Designing pharmaceutical trials for sarcopenia in frail older adults: EU/US Task Force recommendations (Q33828935) (← links)
- A study on relationship between elderly sarcopenia and inflammatory factors IL-6 and TNF-α. (Q33901304) (← links)
- Respiratory chain deficiency in aged spinal motor neurons. (Q33906482) (← links)
- The impact of low muscle mass definition on the prevalence of sarcopenia in older Australians. (Q33930382) (← links)
- The intriguing regulators of muscle mass in sarcopenia and muscular dystrophy (Q34106342) (← links)
- Longitudinal impact of aging on muscle quality in middle-aged men (Q34115979) (← links)
- Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases (Q34145591) (← links)
- Efforts begin to sprout: publications in JCSM on cachexia, sarcopenia and muscle wasting receive attention (Q34156932) (← links)
- Muscle wasting: an overview of recent developments in basic research (Q34156942) (← links)
- Sarcopenia with limited mobility: an international consensus (Q34189767) (← links)
- Recent developments in the treatment of cachexia: highlights from the 6th Cachexia Conference (Q34264508) (← links)
- Highlights of mechanistic and therapeutic cachexia and sarcopenia research 2010 to 2012 and their relevance for cardiology. (Q34334313) (← links)
- Exercise attenuates the major hallmarks of aging (Q34449998) (← links)
- Moving on up: the Journal of Cachexia, Sarcopenia and Muscle (Q34495485) (← links)
- Prevalence, incidence, and clinical impact of sarcopenia: facts, numbers, and epidemiology-update 2014. (Q34591010) (← links)
- Cachexia in heart disease: highlights from the ESC 2010 (Q34716880) (← links)
- Evaluation of early biomarkers of muscle anabolic response to testosterone (Q34716895) (← links)
- Oxidative stress induces caveolin 1 degradation and impairs caveolae functions in skeletal muscle cells (Q35208361) (← links)
- The role of myostatin in muscle wasting: an overview (Q35223987) (← links)
- The epidemiology of sarcopenia in community living older adults: what role does lifestyle play? (Q35223989) (← links)
- Growth hormone, insulin-like growth factor 1, and insulin signaling-a pharmacological target in body wasting and cachexia (Q35569439) (← links)
- Prevalence and definition of sarcopenia in community dwelling older people. Data from the Berlin aging study II (BASE-II). (Q35602843) (← links)
- Meal-based enhancement of protein quality and quantity during weight loss in obese older adults with mobility limitations: rationale and design for the MEASUR-UP trial (Q35626325) (← links)
- Not being able to see the muscle for the fat. (Q35828094) (← links)
- Plasma heat shock protein 72 as a biomarker of sarcopenia in elderly people (Q35854605) (← links)
- Sarcopenia and Hearing Loss in Older Koreans: Findings from the Korea National Health and Nutrition Examination Survey (KNHANES) 2010 (Q35957935) (← links)
- Sarcopenia and cachexia: the adaptations of negative regulators of skeletal muscle mass (Q36028202) (← links)
- Evolving concepts on the age-related changes in "muscle quality". (Q36028216) (← links)
- Behavioural changes are a major contributing factor in the reduction of sarcopenia in caloric-restricted ageing mice (Q36074187) (← links)
- A critical review of the long-term disability outcomes following hip fracture (Q36122191) (← links)
- Prognostic Impact of CT-Quantified Muscle and Fat Distribution before and after First-Line-Chemotherapy in Lung Cancer Patients (Q36255549) (← links)
- Lean Body Mass and Bone Health in Urban Adolescents From Northern India (Q36270513) (← links)
- Consilience in sarcopenia of cirrhosis (Q36421047) (← links)
- From muscle wasting to sarcopenia and myopenia: update 2012 (Q36421054) (← links)
- Double-blind, placebo-controlled pilot trial of L-Leucine-enriched amino-acid mixtures on body composition and physical performance in men and women aged 65-75 years (Q36552746) (← links)
- Transcriptional activator TAp63 is upregulated in muscular atrophy during ALS and induces the pro-atrophic ubiquitin ligase Trim63. (Q36673695) (← links)
- Influence of diet, exercise, and serum vitamin d on sarcopenia in postmenopausal women (Q36675256) (← links)